REC — Recordati Industria Chimica E Farmaceutica SpA Income Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapHigh Flyer

Market Cap
€10.22bn
Enterprise Value
€12.26bn
Revenue
€2.62bn

Annual income statement for Recordati Industria Chimica E Farmaceutica SpA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	1,580	1,853	2,082	2,342	2,618
Cost of Revenue
Gross Profit	1,152	1,287	1,423	1,600	1,788
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	1,090	1,411	1,523	1,709	1,953
Operating Profit	490	442	560	632	666
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	463	401	491	547	581
Provision for Income Taxes
Net Income After Taxes	386	312	389	417	444
Minority Interest
Net Income Before Extraordinary Items
Net Income	386	312	389	417	444
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	386	312	389	417	444
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	1.9	1.58	1.72	1.98	2.36
Dividends per Share